Clinical Trial Update: Toripalimab in Combination With Platinum-based Chemotherapy for Mutation-negative Stage IV Oligometastatic NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial exploring toripalimab with platinum-based chemotherapy for mutation-negative stage IV oligometastatic non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Oligometastatic Cancer

Drugs mentioned

• Platinum-based chemotherapy (platinum-based chemotherapy)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Tang-Du Hospital | Conditions: NSCLC Stage IV, Oligometastasis | Phase 2 | Status: UNKNOWN